Children ’ s Robitussin And Dimetapp Cough Medicines Recalled For Potential Overdose Risks

(CNN) — Parents take note: GlaxoSmithKline Consumer Healthcare has voluntarily recalled three lots of its children’s cough syrups — Children’s Robitussin Honey Cough and Chest Congestion DM and Children’s Dimetapp Cold and Cough — due to the products having incorrect dosing cups in their packaging.
That means parents might accidentally overdose a child by putting too much syrup in the cup.
Symptoms of overdose of either product may include impaired coordination, elevated blood pressure, dizziness, seizure, nausea, vomiting, constipation, diarrhea, abdominal pain, hallucinations, among other concerns, according to the US Food and Drug Administration.
Adverse reactions can be reported to MedWatch, the FDA’s Safety Information and Adverse Event Reporting program. Consumers can also call GlaxoSmithKline at 1-800-762-4675, Monday through Friday, 8:00 a.m. to 6:00 p.m. Eastern Standard Time.
The company discovered the error during a review of the products’ packaging, the FDA announced on Thursday.
Children’s cough medicine with incorrect dosing cups (Image credit: FDA)
GlaxoSmithKline found that the cups for Children’s Robitussin Honey cough syrup were missing lines for the 5-milliliter and 10-milliliter graduations and the cups for Children’s Dimetapp were missing the 10-milliliter graduation. Cups for both products only had the 20-milliliter graduation.
“There is a potential risk of accidental overdose if caregivers ...

Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 19, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN Cough Syrup Recall Source Type: news